very small series. The surgical laparoscopic pyloroplasty appeared efficacious but remained technically complicated and risky for a functional disease. 14, 15 More recently, gastric electrical stimulation was evaluated in several randomised studies, although, the outcomes in terms of efficacy were disappointing and essentially focused on chronic vomiting symptoms. [16] [17] [18] [19] [20] Consecutively to the interesting results of laparoscopy and the lack of other options, the technique of gastric peroral endoscopic myotomy (G-POEM) was proposed in 2014. Its principle came from physiological study conducted many years ago by Mearin et al. 21 who showed that there was not exclusively a gastric hypomotility that was involved in gastroparesis, but also pyloric spasm with a defect of gastric clearance. G-POEM has been performed for the first time in the United States, 22 and subsequently in Europe by our team 23 with promising results. Since then, three series have been published including seven, 23 and 30 patients respectively. [24] [25] [26] Those reports showed an initial efficacy rate around 80%, representing the most promising and highest rate achieved in this disease to date. However, they were preliminary results, with short-term follow-up less than 6 months and an incomplete evaluation.
Thus, we present the results of our single centre series focusing on mid-term follow-up and potential predictive factors for success or failure.
| PATIENTS AND METHODS

| Design and inclusion criteria
This was a retrospective analysis of 29 consecutive adult patients treated by G-POEM for severe refractory gastroparesis in our tertiary centre. The refractory nature and the severity of the disease were defined as symptoms evolving for more than 6 months, with failure of all medical therapies (prokinetic), and a mean Gastroparesis
Cardinal Symptoms Index (GCSI) superior to 1.5. The GCSI was validated in several studies as an appropriate severity score for assessing gastroparesis. [27] [28] [29] The patients also needed to have undergone a recent (<6 months) gastroscopy to exclude peptic ulcer and gastric neoplasms. Finally, they were required to have disturbed gastric emptying scintigraphy (GES) defined as half gastric emptying time (HGET) more than 145 minutes or an increased residual percentage at 2 and 4 hours (RPH2> 30% and RPH4>10%, respectively, which are the normal values in our hospital).
All the cases and therapeutic decisions were validated in a multidisciplinary meeting involving gastroenterologists, endoscopists, surgeons and anaesthesiologists. The patients were clearly informed about the procedure including benefits and risks, and all of them gave their consent. Then, they were hospitalised 48 hours prior to the intervention to receive an exclusive liquid diet to avoid a bezoar.
| Perioperative management
The procedures were performed on patients under general anaesthesia with oro-tracheal intubation and placed in supine position.
An intravenous antibiotic prophylaxis was administrated as well as an antiemetic protocol including Prednisolone (60 mg) and Droperidol (1 amp-2.5 mg/1 mL). A therapeutic large operating channel gastroscope was systematically used (3.8 mm, Pentax, Tokyo, Japan) applying CO 2 insufflation. The triangle knife was chosen for the whole procedure, the current settings being Endocut Q (effect 2) for the mucosal opening and Swift Coagulation (35 Watts; Effect 2) for the tunnel dissection and the myotomy.
The different steps were as described in our previous paper 23, 26 and illustrated in figure 1 : the tunnel started in the postero-lateral part of the antrum 5 cm upstream from the pylorus ( Figure 1A , B and C) until reaching the pyloric arch ( Figure 1D ), then a deep retrograde myotomy of the pylorus as well as the antral muscle (2 cm) were performed ( Figure 1E ). The tunnel access was finally closed with endoclips (Instinct clips, Cook Endoscopy, WinstonSalem, NC, USA) ( Figure 1F ).
The patients were kept fasting overnight following the intervention with intravenous antiemetic protocol, until they have been clinically assessed the day after. In the absence of evidence of complication at post-operative day 1 (POD 1), liquid oral intake was authorised, and then from POD 2 mixed and normal meal were gradually introduced. In case of satisfying post-operative course, they were discharged at POD 5, with a prescription of oral proton pump inhibitors for 1 month (40 mg twice a day).
| Follow-up and endpoints
For each patient were recorded the age, sex, aetiology of gastroparesis, previous instrumental treatment undergone, pre-operative mean GCSI and related symptoms (Lickert scale), GES results, duration and outcomes of the endoscopic procedure. They were assessed clinically at 1 months, 3 months, 6 months and then every 6 months based on the mean GCSI and the severity of related symptoms. A post-operative GES was carried out 2 months after the procedure.
The primary endpoint was to evaluate the acute (3 months) and mid-term (6 months) clinical efficacy of the G-POEM procedure, based on the improvement of mean GCSI and symptoms severity.
The secondary endpoints were to document potential post-operative adverse events, the evolution of the GES parameters and their correlation with the clinical course. In addition, univariate and multivariate analyses were carried out to identify risk factor for failure or success, including age, sex, aetiology, level of mean GCSI, and parameters of pre-operative scintigraphy.
| Statistical analysis
The statistical evaluation has been carried out using the software SPSS (IBM, Rochester, MN, USA). The results were presented as mean and standard deviation. A Student's t test has been used to compare the means and determine the significance of the results, and the univariate was made using the Chi-square test and multivariate analysis using linear logistic regression. The P-value was considered as significant if <.05.
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| Patients and procedures characteristics
In total, 29 patients underwent G-POEM for refractory gastroparesis between April 2014 and September 2016. They were 10 men and 19 women with a mean age of 52.8AE17.7 years old. The aetiologies of the disease were decreasingly distributed between idiopathic (52%), diabetes (24%), post-operative (17%) and scleroderma (7%).
Four patients had undergone a previous instrumental treatment such as gastric electrical stimulation and/or pyloric botulinium toxin
injection.
An antro-pyloromyotomy by G-POEM was feasible in 100% of the cases in a mean time of 47 minutes . There were no per-procedural adverse events except capnoperitoneum, which occurred in five cases and was deflated by a puncture with a 16
Gauges trocar in the medio-scapular line, without any clinical consequence. During the post-operative course, three patients suffered from moderate abdominal pain at POD-1, which was easily managed with class 1 or 2 analgesics but rescheduled liquid oral intake to POD-2. Two patients had severe post-operative complications. One presented with post-operative bleeding and peritoneal abscess in the peri-gastric area, because she did not respect our refeeding protocol (she ate 2 hours after the procedure). The bleeding was treated endoscopically (clips), and she was transferred to an intensive care unit for the local peritonitis, which was managed successfully by conservative approach. The other patient had an acute bleeding at POD-1 that stopped spontaneously and did not require any endoscopic treatment. There were no surgery or death related to procedure's complications. All the patients but two (those with complications) could be discharged at POD 5. (Table 1) The median time of follow-up was 10 monthsAE6.4, 3-31 with 26/ 29 patients (89.6%) followed up for 6 months or more. There was only one delayed adverse event: one patient had recurrence of symptoms due to a prepyloric fibrotic relative stenosis due to scar tissue at the level of the tunnel, which was successfully treated by incision using an Insulated Tip knife (Olympus, Tokyo, Japan) with immediate clinical improvement.
| Primary endpoint: 3 and 6 months efficacy
The clinical efficacy at 3 months was 79% (23/29) . When comparing with the overall pre-operative mean GCSI, a significant improvement at 1 month, 3 months and 6 months was observed: 3.3AE0.9 vs 0.95AE0.9, 1AE1.2 and 1.1AE0.9 respectively (Figure 2 ). There was also a significant improvement of all the symptoms taken separately.
Regarding the mid-term follow-up, this clinical efficacy rate at 6 months was 69% (18/26), for whom the efficacy rate at 3 months was already 75% (20/26). Thus, two patients had a recurrence between one and 3 months: one had severe diabetes with renal insufficiency, and the other one was addict to cannabis with a high consumption.
Interestingly, the four patients (diabetic) already treated by gastric electrical stimulation with a device still activated had a good clinical efficacy. One had a transitory dumping syndrome easily addressed with nutritional measures, whereas three had an accelerated transit.
3.3 | Scintigraphic evolution and discordance P=.07) (Figure 1 ). Among the six patients that missed the post-operative GES, the reasons were a clinical failure for three of them, while the others did not attend to the appointment.
T A B L E 1 Characteristics of the patients including demography (age and sex), the different aetiologies of gastroparesis, previous treatments applied and procedure outcomes: procedural time, complications and follow-up 
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A discordance between the clinical condition and the scintigraphic results was observed in six cases (21%), but only one patient had a normalisation of the GES in spite of clinical failure. For the five other patients, the mean GCSI was improved but the GES was still disturbed: worsened in two cases, partially improved in two cases, and unchanged in one case.
| Predictive factors for successs
Regarding the efficacy depending on the aetiologies, the results are reported in table 2. Thus, this efficacy rates at 3 months were 93%
in case of idiopathic gastroparesis, 57% in case of diabetes, 80% in case of post-operative and 50% in case of scleroderma, whereas at 6 months they were 92%, 43%; 50% and 50% respectively.
In univariate analysis, the female sex was significantly (P<.05) associated with a higher risk of failure at 3 months (OR=1.8; 95%CI
[1.2-2.5]), and other aetiologies than diabetes are correlated with higher success rate (OR=3.8; 95%CI [1-14.4] T A B L E 2 Clinical success at 3 and 6 months, and scintigraphic evolution after the G-POEM procedure. The clinical success is better for idiopathic (>90%) and post-operative (80% and 50%) gastroparesis compared to diabetes aetiology. The discordance rate between clinical and gastric emptying scintigraphy (GES) improvement is 21%, in all the cases but one in favour of clinical success (with GES still disturbed) was already represented by the oesophageal POEM and sub-mucosal tunnel tumour resection. 30, 31 It also offers a real new hope for patients with severe gastric motility disorders, which considerably affect their quality of life.
When reviewing the literature, there are three recent series and one case report assessing the G-POEM for a total of 52 patients. [24] [25] [26] Pooled analysis shows a constant technical success, with a clinical success rate (based on the GCSI) reaching 86.5%, a scintigraphic improvement in 75% of the cases, and a low complication rate (Table 3) .
However, they were retrospective studies, with a limited time of follow-up (usually 3 months) and without taking account of the efficacy with regard to the aetiologies. In this paper, we report the outcomes of 29 patients treated for gastroparesis by G-POEM, to confirm our preliminary results in terms of efficacy and safety. This is to date the most important mono-centred study providing homogenous management and procedure. The purpose was also to focus on the mid-term efficacy (>6 months) with a median follow-up of 10 months, and on potential predictive factors for success or failure. All our patients had rigorous inclusion criteria and have been closely followed up with repeated clinical assessments and a GES reevaluation, to achieve homogeneous data and to draw conclusions based on their results.
First, we confirmed a good acute (3 months) efficacy (79%), which is consistent with the rest of the literature. Moreover, the mid-term efficacy at 6 months was 70%, so the outcomes remained very promising for the patients, especially in such pathology in which there are no serious therapeutic alternatives. Indeed, only two patients had a recurrence between 3 and 6 months, one suffering from very severe diabetes with terminal renal insufficiency. Regarding the scintigraphic evaluation, the discordance rate was 21%, but in all the cases but one, the gap was in favour of a clinical improvement despite still disturbed GES. This could be explained by the sensibility of this examination, known to be imperfect, 32, 33 even if a disturbed GES is correlated with the severity of the disorder. 34 Interestingly, all the discordances were observed in case of idiopathic gastroparesis.
The procedure was feasible most often in less than 1 h, without any serious per-procedural events. The reproducibility was very high since you always distinguish the very specific aspect of pyloric arch (white arch) when the pylorus is reached, as soon as the tunnel access is performed at 5 o'clock from the pylorus. Another interesting thing noticed during the dissection was that in case of idiopathic gastroparesis, the sub-mucosal tissue was more fibrotic, oppositely to diabetes, even if we did not record this parameter accurately. This might suggest various physiopathological mechanisms of gastroparesis depending on the aetiology. Anyway, the procedure was safe, without severe postoperative pain or hyperthermia. The capnoperitoneums were easily managed by puncture using a 30 cc syringe placed in the peri-umbilical area on the medio-clavicular line after local rigorous asepsis. There were no intra-procedural hemodynamic or respiratory consequences, neither any recurrence after the procedure. Among the two bleedings, one needed a successful endoscopic clipping and blood transfusion, the other one stopped spontaneously.
Finally, we attempted to identify predictive factors for success or failure, facing of the various efficacy rates depending on the aetiologies: 92% for idiopathic, 80% for post-operative and 57% for diabetes.
Thus, in univariate analysis, the female gender and the diabetes were significantly associated with failure, while in the meantime, the idiopathic and post-operative aetiologies were predictive of success.
These statements are consistent with our clinical impressions. Our hypothesis with regard to diabetes is that the motility disorder does not only affect the stomach, but also the rest of the small bowel, leading to worse outcomes. However, in multivariate analysis, these trends
were not statistically confirmed, probably because of the insufficient sample in each group. Very interestingly, when looking at the literature focused on gastric electrical stimulation, it appears that the efficacy is significantly higher in patients with vomiting, and mainly in those with diabetic gastroparesis. Oppositely, the outcomes were disappointing, with around 70% failure, in idiopathic diseases. 16, 17 This statement could be a very promising field of research, to provide the patients a personalised therapeutic approach depending on the aetiology or the main symptoms. This could also open the door to a combined approach to increase the efficacy.
In conclusion, the G-POEM is safe and effective for treating refractory gastroparesis, with an acute and mid-term efficacy very
promising. There is a clear trend in disfavour of female gender and diabetes for the clinical success of the procedure. This is now the time for launching prospective randomised studies to confirm these results, as well as largest sample for more statistically relevant subgroup analyses.
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T A B L E 3 Review of the literature including the major published series of G-POEM, showing an overall efficacy of 86.5%, a scintigraphic improvement of 81% with 9.6% of adverse events 
